Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Nov 17;101(10):1651-7.
doi: 10.1038/sj.bjc.6605350. Epub 2009 Sep 29.

Preclinical mouse models for BRCA1-associated breast cancer

Affiliations
Review

Preclinical mouse models for BRCA1-associated breast cancer

R M Drost et al. Br J Cancer. .

Abstract

A substantial part of all hereditary breast cancer cases is caused by BRCA1 germline mutations. In this review, we will discuss the insights into BRCA1 functions that we obtained from mouse models with conventional and conditional mutations in Brca1. The most advanced models closely resemble human BRCA1-related breast cancer and may therefore be useful for addressing clinically relevant questions.

PubMed Disclaimer

References

    1. Ben David Y, Chetrit A, Hirsh-Yechezkel G, Friedman E, Beck BD, Beller U, Ben-Baruch G, Fishman A, Levavi H, Lubin F, Menczer J, Piura B, Struewing JP, Modan B (2002) Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. J Clin Oncol 2: 463–466 - PubMed
    1. Brodie SG, Xu X, Qiao W, Li WM, Cao L, Deng CX (2001) Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice. Oncogene 20: 7514–7523 - PubMed
    1. Byrski T, Gronwald J, Huzarski T, Grzybowska E, Budryk M, Stawicka M, Mierzwa T, Szwiec M, oelig;niowski R, Siolek M, Narod SA, Lubinski J (2008) Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers. Breast Cancer Res Treat 108: 289–296 - PubMed
    1. Byrski T, Huzarski T, Dent R, Gronwald J, Zuziak D, Cybulski C, Kladny J, Gorski B, Lubinski J, Narod SA (2009) Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res Treat 115: 359–363 - PubMed
    1. Chandler J, Hohenstein P, Swing DA, Tessarollo L, Sharan K (2001) Human BRCA1 gene rescues the embryonic lethality of Brca1 mutant mice. Genesis 29: 72–77 - PubMed

Publication types